All articles by Aninda Chakraborty

Aninda Chakraborty

UK to double troops in Estonia amid Ukraine crisis

The UK has also got 1,000 personnel ready to support humanitarian responses, if required.

Incyte’s Covid-19 associated ARDS study fails to meet primary endpoint

Incyte has announced that its Phase III DEVENT study of ruxolitinib for treating patients on mechanical ventilation with Covid-19 associated Acute Respiratory Distress Syndrome (ARDS) failed to meet its primary endpoint.

Medolife Rx reports positive data from Covid-19 drug candidate study

Quanta subsidiary Medolife Rx has reported positive results from a study that assessed the safety and toxicity of a polarised drug candidate to treat Covid-19 patients.

Gilead and Novo Nordisk expand collaboration for NASH clinical study

Gilead Sciences and Novo Nordisk have agreed to expand their clinical collaboration in non-alcoholic steatohepatitis (NASH) to conduct a larger trial later this year.

Arch Biopartners secures approval to amend LSALT Peptide trial protocols

Canadian firm Arch Biopartners has secured approval to make certain protocol amendments to the Phase II trial of its lead drug LSALT peptide (Metablok).

Gilead and Merck partner to co-develop long-acting HIV treatments

Gilead Sciences and Merck have signed an agreement to co-develop and co-commercialise long-acting treatments for HIV.

Medicago and GSK initiate late-stage study of adjuvanted Covid vaccine

Canada’s Medicago has started a late-stage study of its plant-derived Covid-19 vaccine candidate combined with GSK’s pandemic adjuvant.